PNW
50
-2
USB
48
-2
DUK
49
2
GWW
46
-2
LEG
43
3
HPE
35
2
OKE
48
6
ACN
29
-11
FAST
42
-2
JNPR
49
4
COST
50
2
KO
39
-13
ORLY
47
3
BWA
37
-4
PCAR
23
-4
PRU
45
-9
NWS
70
2
JCI
57
7
NWSA
75
2
HUM
37
-2
PNW
50
-2
USB
48
-2
DUK
49
2
GWW
46
-2
LEG
43
3
HPE
35
2
OKE
48
6
ACN
29
-11
FAST
42
-2
JNPR
49
4
COST
50
2
KO
39
-13
ORLY
47
3
BWA
37
-4
PCAR
23
-4
PRU
45
-9
NWS
70
2
JCI
57
7
NWSA
75
2
HUM
37
-2
Financhill
Back

Corbus Pharmaceuticals Holdings 10K Form

Sell
27

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
$8.20
Seasonality Move:
-5.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRBP News And Ratings

See the #1 stock for the next 7 days that we like better than CRBP

CRBP Financial Statistics

Sales & Book Value

Annual Sales: $881.7K
Cash Flow: $-10.9M
Price / Cash Flow: 0
Annual Sales: $10.39
Price / Book: 0.79

Profitability

EPS (TTM): -4.22000
Net Income (TTM): $-50.3M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Corbus Pharmaceuticals Holdings Earnings Forecast

Key Corbus Pharmaceuticals Holdings Financial Ratios

  • The Selling, General & Administrative Expenses for CRBP have been equal to 2,316.57% of Gross Profit Margin.
  • Per Share Earnings over the last 12 years have been positive in 3 years.

Corbus Pharmaceuticals Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRBP
CUSIP: 21833P
Website: corbuspharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRBP Technical Analysis vs Fundamental Analysis

Sell
27
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy or a Sell?